GO:0060076 excitatory synapse: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060076 excitatory synapse is a cellular component defined as a synapse in which an action potential in the presynaptic cell increases the probability of an action potential in the postsynaptic cell.
• Excitatory synapses are highly diverse in molecular composition across brain regions and cell types, as revealed by proteomic profiling.
• Sleep plays a critical role in maintaining the diversity of excitatory synapses in the cortex and hippocampus.
• Complement C1q-dependent elimination of excitatory synapses by astrocytes and microglia contributes to Alzheimer's disease pathology in mouse models.
• Serotonergic modulation influences excitatory synapse development and plasticity, linking neuromodulatory systems to synaptic function.
• The excitatory synapse hypothesis of depression posits that deficits in excitatory synaptic transmission underlie depressive disorders.
Description
Excitatory synapses are the primary sites of information transfer in the brain, where action potentials in presynaptic neurons increase the probability of firing in postsynaptic neurons. This cellular component, annotated as GO:0060076, is fundamental to neural circuit function, learning, and memory. Researchers study excitatory synapses to understand normal brain physiology and the pathological mechanisms underlying neurological and psychiatric disorders. The molecular architecture of excitatory synapses is highly complex, involving hundreds of proteins that mediate neurotransmitter release, reception, and signal transduction. Recent advances in proteomics and imaging have revealed remarkable diversity among excitatory synapses across different brain regions and cell types. This article provides a comprehensive overview of the structure, function, regulation, and research methods related to GO:0060076, based on authoritative QuickGO data and verified PubMed literature.
excitatory synapse At A Glance
| GO ID | GO:0060076 |
|---|---|
| GO term | excitatory synapse |
| Ontology | cellular_component |
| Synonym | none |
| Definition | A synapse in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell. |
| Major function | Mediates excitatory neurotransmission, enabling information transfer and plasticity in neural circuits. |
| Location | Primarily on dendritic spines of postsynaptic neurons and axon terminals of presynaptic neurons. |
| Key neurotransmitter | Glutamate (in most excitatory synapses). |
| Major protein components | Glutamate receptors (AMPA, NMDA), scaffolding proteins (PSD-95), adhesion molecules (neuroligins, neurexins). |
What Is GO:0060076?
According to the Gene Ontology, GO:0060076 excitatory synapse is a cellular component defined as a synapse in which an action potential in the presynaptic cell increases the probability of an action potential occurring in the postsynaptic cell. In simpler terms, it is a specialized junction between two neurons where the presynaptic neuron releases neurotransmitters that typically depolarize the postsynaptic neuron, making it more likely to fire an action potential. This definition distinguishes excitatory synapses from inhibitory synapses, which decrease the probability of postsynaptic firing. Excitatory synapses are characterized by asymmetric structures, often with round synaptic vesicles and thick postsynaptic densities, and they primarily use glutamate as the neurotransmitter.
Why Is excitatory synapse Important in Cell Biology?
Excitatory synapses are essential for virtually all brain functions, including sensory perception, motor control, learning, and memory. Their dysfunction is implicated in numerous neurological and psychiatric disorders, such as Alzheimer's disease, depression, and autism spectrum disorders. Understanding the molecular composition and regulation of excitatory synapses is critical for developing targeted therapies. Moreover, excitatory synapse diversity across brain regions and cell types underscores the need for precise experimental models to study their unique properties.
• Excitatory synapses are the main sites of information transfer in the brain, enabling neural circuit function.
• They are critical for synaptic plasticity, including long-term potentiation (LTP), a cellular correlate of learning and memory.
• Dysfunction of excitatory synapses is linked to Alzheimer's disease through complement-dependent synapse elimination.
• The excitatory synapse hypothesis of depression suggests that deficits in excitatory transmission contribute to mood disorders.
• Sleep maintains excitatory synapse diversity, highlighting their role in homeostatic regulation.
• Serotonergic modulation of excitatory synapse development and plasticity links neuromodulators to synaptic function.
• Excitatory synapse proteomic diversity across brain regions informs region-specific functions and vulnerabilities.
• Microglial and astrocytic interactions with excitatory synapses are crucial for developmental pruning and function.
• Excitatory synapse components are potential therapeutic targets for neurological and psychiatric disorders.
• Research on excitatory synapses benefits from advanced CRISPR models to dissect gene function in vivo and in vitro.
Structure and Composition of excitatory synapse
Presynaptic Terminal and Neurotransmitter Release
In simple terms: The presynaptic side of an excitatory synapse is like a sending station that releases chemical signals.
The presynaptic terminal of an excitatory synapse contains synaptic vesicles filled with glutamate. Upon arrival of an action potential, voltage-gated calcium channels open, triggering vesicle fusion and glutamate release into the synaptic cleft. This process is tightly regulated by proteins such as SNAREs and synaptotagmins. The architecture of the presynaptic active zone ensures precise and rapid neurotransmitter release.
Postsynaptic Density and Receptor Clustering
In simple terms: The postsynaptic side is like a receiving station with receptors that catch the chemical signals.
The postsynaptic density (PSD) is a dense protein network that clusters glutamate receptors, including AMPA and NMDA receptors, opposite the presynaptic release site. Scaffolding proteins such as PSD-95 bind to receptor subunits and organize signaling complexes. This organization is critical for efficient synaptic transmission and plasticity.
Synaptic Cleft and Adhesion Molecules
In simple terms: The synaptic cleft is the gap between neurons, and adhesion molecules hold the two sides together.
The synaptic cleft is a narrow extracellular space across which glutamate diffuses. Cell adhesion molecules, such as neuroligins and neurexins, span the cleft and mediate trans-synaptic adhesion, ensuring proper alignment of presynaptic and postsynaptic specializations. These molecules also play roles in synapse formation and specification.
Molecular Diversity of Excitatory Synapses
In simple terms: Excitatory synapses are not all the same; they have different protein compositions depending on where they are in the brain.
Proteomic studies have revealed that excitatory synapses exhibit remarkable molecular diversity across brain regions and cell types. This diversity underlies functional differences and may contribute to selective vulnerability in disease. For example, synaptic proteins vary between cortical layers and hippocampal subregions.
Glial Interactions with Excitatory Synapses
In simple terms: Support cells in the brain, called glia, also interact with excitatory synapses and can modify them.
Astrocytes and microglia actively participate in the formation, maintenance, and elimination of excitatory synapses. Microglia can prune synapses via complement-dependent mechanisms, which are implicated in Alzheimer's disease. Astrocytes contribute to synapse development and function through secreted factors.
Key Genes Involved in GO:0060076 excitatory synapse
The following genes encode key proteins that constitute or regulate excitatory synapses, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRIN1 | NMDA receptor subunit | Critical for synaptic plasticity and excitotoxicity; implicated in schizophrenia and Alzheimer's disease. |
| GRIN2A | NMDA receptor subunit | Modulates receptor properties; mutations linked to epilepsy and intellectual disability. |
| GRIN2B | NMDA receptor subunit | Involved in learning and memory; mutations associated with neurodevelopmental disorders. |
| GRIA1 | AMPA receptor subunit | Mediates fast excitatory transmission; key for LTP and memory. |
| GRIA2 | AMPA receptor subunit | Controls calcium permeability; important for synaptic function. |
| DLG4 | PSD-95 scaffolding protein | Organizes postsynaptic density; regulates receptor clustering and signaling. |
| NLGN1 | Neuroligin 1 | Postsynaptic adhesion molecule; involved in synapse formation and autism. |
| NRXN1 | Neurexin 1 | Presynaptic adhesion molecule; mutations linked to autism and schizophrenia. |
| SHANK3 | Scaffolding protein | Organizes postsynaptic density; mutations cause Phelan-McDermid syndrome. |
| C1QA | Complement component | Mediates synapse elimination by microglia; implicated in Alzheimer's disease. |
| IL34 | Interleukin-34 | Supports microglial function; involved in cortical development. |
| SYP | Synaptophysin | Presynaptic vesicle protein; marker of synaptic density. |
| SNAP25 | SNARE protein | Essential for neurotransmitter release; mutations cause neurodevelopmental disorders. |
| GRM5 | Metabotropic glutamate receptor 5 | Modulates synaptic transmission; target for psychiatric disorders. |
| CAMK2A | Calcium/calmodulin-dependent kinase II | Key regulator of synaptic plasticity and LTP. |
| ARC | Activity-regulated cytoskeleton-associated protein | Immediate early gene; involved in synaptic plasticity. |
| BDNF | Brain-derived neurotrophic factor | Promotes synaptic development and plasticity; linked to depression. |
| HTR1A | Serotonin receptor 1A | Modulates excitatory synapse development and plasticity. |
How Is excitatory synapse Regulated?
Excitatory synapse formation, maintenance, and elimination are regulated by diverse mechanisms. Complement C1q-dependent signaling mediates synapse elimination by astrocytes and microglia, a process implicated in Alzheimer's disease. Sleep maintains excitatory synapse diversity, suggesting homeostatic regulation across wake-sleep cycles. Serotonergic signaling modulates excitatory synapse development and plasticity, linking neuromodulatory systems to synaptic regulation. Microglia-derived factors, such as interleukin-34, support cortical developmental microglia function and indirectly influence synapses. Additionally, the excitatory synapse hypothesis of depression posits that stress and neuroinflammation disrupt excitatory synaptic transmission, contributing to mood disorders.
excitatory synapse and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| C1QA | Alzheimer's disease; synapse elimination | Knockout mouse; complement inhibition |
| GRIN2B | Neurodevelopmental disorders; NMDA receptor dysfunction | Point mutation knock-in mouse; iPSC-derived neurons |
| NLGN1 | Autism spectrum disorder; synapse formation | Overexpression and knockout models in mice |
| SHANK3 | Phelan-McDermid syndrome; synaptic scaffolding | Knockout rat; patient-derived organoids |
| HTR1A | Depression; serotonergic modulation | Knockout mouse; pharmacological studies |
Alzheimer's Disease
In Alzheimer's disease, complement C1q-dependent elimination of excitatory synapses by astrocytes and microglia leads to synaptic loss, a hallmark of the disease. This process is mediated by the complement cascade and contributes to cognitive decline. Mouse models have been instrumental in elucidating these mechanisms.
Depression
The excitatory synapse hypothesis of depression proposes that deficits in excitatory synaptic transmission underlie depressive symptoms. Chronic stress and neuroinflammation can impair excitatory synapse function, and rapid-acting antidepressants like ketamine may work by restoring excitatory synaptic strength.
Neurodevelopmental Disorders
Mutations in genes encoding excitatory synapse proteins, such as NLGN1, NRXN1, and SHANK3, are associated with autism spectrum disorders and schizophrenia. These mutations disrupt synapse formation and function, leading to altered neural circuit development.
From excitatory synapse-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate excitatory synapse density? | Knockout mouse or CRISPR KO in primary neurons |
| Does a point mutation in gene Y alter synaptic transmission? | Point mutation knock-in mouse or iPSC-derived neurons |
| How does gene Z overexpression affect synaptic plasticity? | Overexpression via viral vectors in vivo |
| Where is protein W localized in excitatory synapses? | Tagged knock-in with fluorescent protein |
| What is the role of gene V in synapse elimination? | Conditional knockout in microglia or astrocytes |
| Does gene U mutation affect behavior? | Knock-in mouse with behavioral assays |
How to Study the excitatory synapse Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry proteomics | Protein composition of synaptic fractions | Identifying synaptic diversity across brain regions |
| Confocal microscopy | Synaptic puncta density and colocalization | Assessing synapse formation and elimination |
| Electrophysiology | Synaptic transmission strength and plasticity | Measuring LTP and LTD in brain slices |
| RNA sequencing | Transcriptional profiles of neurons | Identifying gene expression changes in disease models |
| Ribosome profiling | Translational efficiency of mRNAs | Studying activity-dependent translation at synapses |
| CRISPR knockout | Gene function loss | Determining necessity of genes for synapse formation |
| Overexpression | Gain-of-function effects | Testing sufficiency of genes in synapse regulation |
| Behavioral assays | Cognitive and emotional phenotypes | Linking synaptic changes to behavior |
Proteomic Profiling of Excitatory Synapses
Mass spectrometry-based proteomics can characterize the molecular composition of excitatory synapses across brain regions and cell types. This approach reveals synaptic diversity and identifies novel components. It requires biochemical enrichment of synaptic fractions followed by high-resolution mass spectrometry.
Imaging Synaptic Structure and Function
Advanced imaging techniques, such as confocal and super-resolution microscopy, allow visualization of synaptic proteins and structures. Electrophysiology combined with imaging measures synaptic transmission and plasticity. These methods are essential for validating molecular findings.
Transcriptomic and Translational Profiling
RNA sequencing and ribosome profiling can reveal gene expression changes in excitatory synapses under different conditions. Sleep studies have used these methods to show maintenance of synapse diversity. Such approaches identify regulatory mechanisms and potential therapeutic targets.
Genetic and Pharmacological Manipulation
CRISPR-based gene editing and pharmacological agents can manipulate excitatory synapse components in vitro and in vivo. These tools help establish causality and test therapeutic interventions. For example, complement inhibitors prevent synapse loss in Alzheimer's models.
How CRISPR Can Be Used to Study GO:0060076 excitatory synapse
Knockout
CRISPR knockout (KO) is used to delete genes encoding excitatory synapse proteins to study their necessity. For example, KO of C1qa in mice prevents synapse elimination in Alzheimer's models. KO of NLGN1 or NRXN1 disrupts synapse formation and function. These models help establish causal roles in synaptic physiology and behavior.
Point Mutation
Point mutation knock-in models introduce specific disease-associated mutations into endogenous genes. For instance, mutations in GRIN2B linked to neurodevelopmental disorders can be modeled in mice or iPSCs to study receptor dysfunction. Such models provide insights into molecular mechanisms and potential therapies.
Knock-in
Knock-in of reporter tags, such as fluorescent proteins, allows visualization of endogenous synaptic proteins. Tagged knock-in of PSD-95 or AMPA receptor subunits enables live imaging of synapse dynamics. This approach is valuable for tracking synaptic changes in health and disease.
Overexpression
Overexpression of excitatory synapse genes via viral vectors or transgenic models tests gain-of-function effects. For example, overexpression of BDNF enhances synaptic plasticity and has antidepressant-like effects. Overexpression models help identify sufficiency and potential therapeutic targets.
How EDITGENE Supports excitatory synapse Research
Researchers studying excitatory synapse-related genes often need to determine whether a candidate gene is causally involved in synapse formation, function, or elimination. EDITGENE provides comprehensive CRISPR-based services to generate precise cell and animal models, enabling rigorous investigation of gene function in the context of GO:0060076.
Contact EDITGENE today to design your custom CRISPR model for excitatory synapse research.
Frequently Asked Questions About excitatory synapse
What is an excitatory synapse?
An excitatory synapse is a specialized junction between neurons where an action potential in the presynaptic cell increases the probability of an action potential in the postsynaptic cell, as defined by GO:0060076.
What genes are involved in excitatory synapses?
Key genes include GRIN1, GRIN2A, GRIN2B, GRIA1, GRIA2, DLG4, NLGN1, NRXN1, SHANK3, and others encoding receptors, scaffolds, and adhesion molecules.
What is the function of GO:0060076?
GO:0060076 excitatory synapse functions as the primary site of excitatory neurotransmission, enabling information transfer, plasticity, and neural circuit activity.
How are excitatory synapses eliminated in Alzheimer's disease?
Complement C1q-dependent mechanisms mediate synapse elimination by astrocytes and microglia in Alzheimer's disease models.
Does sleep affect excitatory synapses?
Yes, sleep maintains excitatory synapse diversity in the cortex and hippocampus, as shown by recent studies.
What is the excitatory synapse hypothesis of depression?
It proposes that deficits in excitatory synaptic transmission underlie depressive disorders, and restoring excitatory synapses may have antidepressant effects.
How can CRISPR be used to study excitatory synapses?
CRISPR can generate knockout, point mutation, knock-in, and overexpression models to dissect gene function in excitatory synapse formation, function, and elimination.
What methods are used to study excitatory synapses?
Common methods include proteomics, imaging, electrophysiology, RNA sequencing, and CRISPR-based genetic manipulation.
What is the molecular diversity of excitatory synapses?
Excitatory synapses exhibit diverse protein compositions across brain regions and cell types, as revealed by proteomic profiling.
How do microglia interact with excitatory synapses?
Microglia can prune excitatory synapses via complement-dependent mechanisms and support synaptic function through secreted factors like interleukin-34.
Conclusion
GO:0060076 excitatory synapse is a fundamental cellular component that mediates excitatory neurotransmission and plasticity in the brain. Its molecular complexity and diversity are increasingly appreciated through proteomic and genetic studies. Dysregulation of excitatory synapses is implicated in major neurological and psychiatric disorders, making them key targets for therapeutic development. Advanced CRISPR models and multi-omic approaches will continue to unravel the mechanisms governing excitatory synapse function and dysfunction.
References
- 1. Dejanovic B et al.. 2022. Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer's disease mouse models.. Nat Aging 2(9):837-850 PMID: 37118504
- 2. Koukaroudi D et al.. 2024. Sleep maintains excitatory synapse diversity in the cortex and hippocampus.. Curr Biol 34(16):3836-3843.e5 PMID: 39096907
- 3. Devlin BA et al.. 2025. Excitatory-neuron-derived interleukin-34 supports cortical developmental microglia function.. Immunity 58(8):1948-1965.e6 PMID: 40609535
- 4. Chang VN et al.. 2026. Serotonergic modulation of excitatory synapse development and plasticity.. Mol Cells 49(5):100346 PMID: 41819288
- 5. Thompson SM et al.. 2015. An excitatory synapse hypothesis of depression.. Trends Neurosci 38(5):279-94 PMID: 25887240
- 6. Favuzzi E et al.. 2018. Molecular diversity underlying cortical excitatory and inhibitory synapse development.. Curr Opin Neurobiol 53:8-15 PMID: 29704699
- 7. Chua JJ et al.. 2010. The architecture of an excitatory synapse.. J Cell Sci 123(Pt 6):819-23 PMID: 20200227
- 8. van Oostrum M et al.. 2023. The proteomic landscape of synaptic diversity across brain regions and cell types.. Cell 186(24):5411-5427.e23 PMID: 37918396
